Pulmonary Vascular Resistance Abnormality

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pulmonary Vascular Resistance Abnormality trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06331208

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

Heart failure (HF) patients often develop pulmonary hypertension (PH) that leads to transition into a biventricular HF with poor prognosis. There are two PH co…

Czechia230 participantsStarted 2024-08-23

Treatment: non-contrast chest CT, spirometry with diffusing lung capacity for carbon monoxide (DLCO) analysis

All recent trials (7 shown)

Active — Not RecruitingNot Applicable

NCT03404258

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary…

This is a novel preliminary study of biomarkers of pathologic pre-operative pulmonary vascular development, elevated pre-operative Pulmonary Vascular Resistance…

United States50 participantsStarted 2018-02-10

Treatment: Research Blood Sampling

CompletedNot Applicable

NCT04718350

Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents

The aim of this study is to examine and compare the effect of Levosimendan and Milrinone administered intravenously and via inhalation respectively in cardiac s…

Greece40 participantsStarted 2021-01-27

Treatment: levosimendan at a dose of 6 mcg/kg, milrinone at a dose of 50 mcg/kg

Pulmonary Vascular Resistance Abnormality

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

All recent trials (7 shown)

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary…

Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

All recent trials (7 shown)

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary…

Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents

PV Loop and Pulmonary Hypertension

Levosimendan Administration in Pulmonary Hypertension

Iron Status and Cardiopulmonary Physiology

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure